Séverine et al. suggested that IL-34 prolongs survival in humanized acute GVHD models by increasing the expansion of Tregs rather than stimulating the transformation of naïve T cells to Tregs [25], which partly explained why IL-34 failed to induce Treg differentiation directly in vitro. The gene discussed is IL34; the disease is acute graft versus host disease.